Invention Grant
- Patent Title: Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer
-
Application No.: US14897122Application Date: 2014-06-11
-
Publication No.: US10174117B2Publication Date: 2019-01-08
- Inventor: Daniel Baty , Patrick Chames , Brigitte Kerfelec , Marc Turini
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) , UNIVERSITE D'AIX MARSEILLE , INSTITUT JEAN PAOLI & IRENE CALMETTES
- Applicant Address: FR Paris FR Paris FR Marseilles FR Marseilles
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),UNIVERSITE D'AIX MARSEILLE,INSTITUT JEAN PAOLI & IRENE CALMETTES
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS),UNIVERSITE D'AIX MARSEILLE,INSTITUT JEAN PAOLI & IRENE CALMETTES
- Current Assignee Address: FR Paris FR Paris FR Marseilles FR Marseilles
- Agency: Whitham & Cook, P.C.
- Priority: EP13305791 20130611
- International Application: PCT/EP2014/062075 WO 20140611
- International Announcement: WO2014/198748 WO 20141218
- Main IPC: C07K16/32
- IPC: C07K16/32 ; C07K16/28 ; A61K39/00
Abstract:
The present invention relates to anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer.
Public/Granted literature
- US20160122432A1 ANTI-HER2 SINGLE DOMAIN ANTIBODIES, POLYPEPTIDES COMPRISING THEREOF AND THEIR USE FOR TREATING CANCER Public/Granted day:2016-05-05
Information query
